TSIEX06:	Subjects Who Received Study Treatment Over Time; Safety Analysis Set (Study jjcs - core)					
 	Active Study Agent 	Active Study Agent 	Active Study Agent 	 	
 	Xanomeline High Dose 	Xanomeline Low Dose 	Combined 	Placebo 	
  	N=53 	N=73 	N=126 	N=59 	
Subjects receiving study treatment, n (%) 	 	 	 	 	
Baseline 	30 (56.6%) 	42 (57.5%) 	72 (57.1%) 	21 (35.6%) 	
Week 2 	27 (50.9%) 	16 (21.9%) 	43 (34.1%) 	28 (47.5%) 	
Week 24 	14 (26.4%) 	8 (11.0%) 	22 (17.5%) 	19 (32.2%)